Stablecoin Development Corporation (SDEV)
SDEV trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.25
-11.35% on the day
Market cap
$64.7M
Micro cap
Revenue · 2024
$9.8M
No prior year to compare
Net income · 2024
-$7.2M
-73.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/1389545/000143774925010730/0001437749-25-010730-index.htm. Net income: SEC 10-K/A (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SDEV on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001389545 |
| SEC industry code | Finance Services |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $9.8M |
| Net income | -$7.2M |
| Operating income | -$7.4M |
| Net margin | -73.8% |
| Operating margin | -75.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $430K |
| Total assets | $3.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 6.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3 | S-3 | 2026-08-11 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-29 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-07-30 |
| Latest current report FORM 8-K | 8-K | 2026-10-05 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-09-28 |
Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| FBIO | Fortress Biotech Inc. | $1.95 | -7.58% | $65.0M |
| RNTX | Rein Therapeutics Inc. | $0.7546 | -3.86% | $65.1M |
| ONCY | Oncolytics Biotech Inc. | $0.4900 | +3.53% | $64.2M |
| XBIT | XBiotech Inc. | $2.16 | -5.68% | $65.9M |
| SPRO | Spero Therapeutics Inc. | $1.15 | -2.54% | $67.0M |
| OSTX | OS Therapies Incorporated | $1.45 | -7.05% | $67.4M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier